News
-
Professor Frances Separovic is ready to take her place as a leader in STEMM and as a Homeward Bound participant. Her achievements across biophysical chemistry make her a valued addition on this journey.
-
Researchers have found a way to stop the rabies virus shutting down the body’s immune defence against it. In doing so they have solved a key scientific puzzle and have laid the foundation for the development of new anti-rabies vaccines.
-
Meet Yan Hong Tan, Melbourne Protein Characterisation & ACRF Facility for Innovative Cancer Drug Discovery, acting Centre Manager
-
Genetic variation is critical to allow populations to adapt to current and future environmental stresses. Read Pursuit piece by Bio21's Ary Hoffmann...
-
Professor Leann Tilley and Dr Stanley Xie from the Bio21 Institute are working with experts from the Japanese company, Takeda Pharmaceuticals, and Swiss-based foundation, Medicines for Malaria Venture (MMV), in a double-pronged effort to develop new antimalarial drugs.
-
Melbourne Dental School Head of School Mike Morgan, CSL Senior Vice President of Research Andrew Nash, University of Melbourne Vice-President (Enterprise) Doron Ben-Meir, COHR CEO & Director of Research Eric Reynolds, Member for Higgins Katie Allen and Brandon Capital Investment Manager Ingmar Wahlqvist at the launch of Denteric.
-
New research was published today [Cell Host and Microbe, 11 September] that shows how an important group of human pathogens cause disease, opening up fresh avenues for much needed therapies.
-
Congratulations to Bio21's Leann Tilley and David Ascher, who have received NHMRC Development and Investigator grants respectively.
-
An exciting new microscope has been installed in the Biochemistry and Molecular Biology Node of the Biological Optical Microscopy Platform at the Bio21 Institute, 28 August 2019.
-
Read about Justine Mintern, Biochemistry and Molecular Biology, Head of Vaccine Biology Lab